Osteoporosis in Rheumatology.

Area of Science:

• Rheumatology
• Endocrinology
• Bone Metabolism

Background:

• Osteoporosis is a frequent comorbidity in patients diagnosed with rheumatic diseases.
• It is commonly associated with rheumatoid arthritis, spondyloarthropathy, systemic lupus erythematosus, and other autoimmune rheumatic conditions.

Purpose of the Study:

• To highlight the link between rheumatic diseases and osteoporosis.
• To discuss factors influencing osteoporosis incidence in this patient population.
• To emphasize the importance of management strategies.

Main Methods:

• Literature review of osteoporosis in rheumatic diseases.
• Analysis of risk factors and contributing elements.
• Synthesis of current management guidelines.

Main Results:

• Rheumatic diseases significantly increase osteoporosis risk.
• Key influencing factors include uncontrolled disease activity, prolonged high-dose steroid use, immobility, advanced age, and postmenopausal status.
• Effective management involves disease control, steroid dose minimization, and adequate vitamin D and calcium supplementation.

Conclusions:

• Controlling underlying rheumatic disease and optimizing medication use are vital for preventing osteoporosis.
• Regular screening and appropriate management of osteoporosis are essential for reducing morbidity and mortality in affected patients.